Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1

Abstract

Objective

We hypothesized that autoaggressive immune responses observed in multiple sclerosis (MS) could be associated with an imbalance in proportion of immune cell subsets and in cytokine production in response to infection, including viruses.

Methods

We collected blood mononuclear cells (MNC) from 23 patients with MS and 23 sex- and age-matched healthy controls (HC) from the island of Sardinia, Italy, where the prevalence of MS is extraordinarily high. Using flow cytometry, we studied MNC for expression of blood dendritic cell antigens (BDCA)-2 and BDCA-4 surface markers reflecting the proportion of plasmacytoid dendritic cells (pDC) that produce type I interferons (IFNs) after virus challenge and promote Th2/anti-inflammtory cytokine production. In parallel, pro-inflammatory (interleukin [IL]-2, IL-12, IFN-γ), anti-inflammatory (IL-4, IL-10), and immuno-regulatory/pleiotropic cytokines (type I IFNs including IFN-α and β, IL-6) were measured before and after an in vitro exposure to herpes simplex virus type 1 (HSV-1).

Results

The subset of lineage negative (lin⁻), BDCA-2⁺ cells was lower in patients with MS compared with HC (0.08 ± 0.02% vs 0.24 ± 0.02%; P < 0.001). A similar pattern was observed for lin⁻BDCA-4⁺ cells (0.08 ± 0.02% vs 0.17% ± 0.03; P < 0.01). Spontaneous productions of IL-6 (45 ± 10 pg/mL vs 140 ± 26 pg/mL; P < 0.01) and IL-10 (17 ± 0.4 pg/mL vs 21 ± 1 pg/mL; P < 0.05) by MNC were lower in patients with MS compared with HC. Spontaneous production of IL-6 (6.5 ± 0.15 pg/mL vs 21 ± 5 pg/mL; P < 0.01 and IL-10 (11 ± 1 pg/mL vs 14 ± 3 pg/mL; P < 0.05) by pDC was also lower in patients with MS compared with HC. Exposure of MNC to HSV-1 showed, in both patients with MS and HC, increased production of IFN-α, IL-6, and IL-10 but decreased production of IL-4. In response to HSV-1 exposure, productions of IL-6 (165 ± 28 pg/mL vs 325 ± 35 pg/mL; P < 0.01) and IL-10 (27 ± 3 vs 33 ± 3 P < 0.05) by MNC as well as by pDC (IL-6: 28 ± 7 vs 39 ± 12 P < 0.05; IL-10: 14 ± 1 vs 16 ± 3 P < 0.05) were lower in patients with MS compared with HC.

Conclusion

The results implicate a new evidence for altered immune cells and reduced immune responses in response to viral challenge in MS.

Keywords

herpes simplex virus IL-6 IL-12 multiple sclerosis plasmacytoid dendritic cells

Get full access to this article

View all access options for this article.

References

1 Grouard G Durand I Filgueira L Banchereau J Liu YJ . Dendritic cells capable of stimulating T cells in germinal centres. Nature 1996; 384: 364–367.

2 Steinman RM Hemmi H . Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17–58.

3 O'Doherty U Peng M Gezelter S . Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487–493.

4 Olweus J BitMansour A Warnke R . Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 1997; 94: 12551–12556.

5 Robinson SP Patterson S English N Davies D Knight SC Reid CD . Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769–2778.

6 Rissoan MC Soumelis V Kadowaki N . Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183–1186.

7 Ito T Kanzler H Duramad O Cao W Liu YJ . Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006; 107: 2423–2431.

8 Kadowaki N Antonenko S Liu YJ . Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 2001; 166: 2291–2295.

9 Svensson H Johannisson A Nikkila T Alm GV Cederblad B . The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry. Scand J Immunol 1996; 44: 164–172.

10.

10 Cella M Jarrossay D Facchetti F . Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919–923.

11.

11 Siegal FP Kadowaki N Shodell M . The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835–1837.

12.

12 Huang YM Hussien Y Yarilin D Xiao BG Liu YJ Link H . Interferon-beta induces the development of type 2 dendritic cells. Cytokine 2001; 13: 264–271.

13.

13 Pashenkov M Teleshova N Link H . Inflammation in the central nervous system: the role for dendritic cells. Brain Pathol 2003; 13: 23–33.

14.

14 Soumelis V Liu YJ . From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 2006; 36: 2286–2292.

15.

15 McRae BL Semnani RT Hayes MP van Seventer GA Type I . IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 1998; 160: 4298–4304.

16.

16 Rudick RA Ransohoff RM Lee JC . In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 1998; 50: 1294–1300.

17.

17 Huang YM Hussien Y Yarilin D Xiao BG Liu YJ Link H . Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. J Neuroimmunol 2001; 121: 102–110.

18.

18 Huang YM Adikari S Bave U Sanna A Alm G . Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production. J Neuroimmunol 2005; 158: 204–212.

19.

19 Sindic CJ Monteyne P Laterre EC . The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 1994; 54: 75–80.

20.

20 Hauser SL Oksenberg JR . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61–76.

21.

21 Traugott U Reinherz EL Raine CS . Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983; 4: 201–221.

22.

22 Link H Huang YM . Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J. Neuroimmunol 2006; 180: 17–28.

23.

23 Huang YM Liu X Steffensen K . Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden. Mult Scler 2005; 11: 16–23.

24.

24 Freedman MS . Disease-modifying drugs for multiple sclerosis: current and future aspects. Expert Opin Pharmacother 2006; 7(Suppl. 1): S1–S9.

25.

25 Lopez C Comabella M Al-zayat H Tintore M Montalban X . Altered maturation of circulating dendritic cells in primary progressive MS patients. J Neuroimmunol 2006; 175: 183–191.

26.

26 Pashenkov M Huang YM Kostulas V Haglund M Soderstrom M Link H . Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 2001; 124: 480–492.

27.

27 Poser CM Paty DW Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

28.

28 Dzionek A Fuchs A Schmidt P Cremer S Zysk M Miltenyi S . BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037–6046.

29.

29 Narbutt J Lesiak A Zak-Prelich M . The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell Mol Biol Lett. 2004; 9: 497–509.

30.

30 Coen DM Furman PA Aschman DP Schaffer PA . Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin. Nucleic Acids Res 1983; 11: 5287–5297.

31.

31 Shogan B Kruse L Mulamba GB Hu A Coen DM . Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B. J Virol 2006; 80: 4740–4747.

32.

32 Stasiolek M Bayas A Kruse N . Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 2006; 129: 1293–1305.

33.

33 Banchereau J Steinman RM . Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.

34.

34 Kuwana M Kaburaki J Wright TM Kawakami Y Ikeda Y . Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 2001; 31: 2547–2557.

35.

35 Liu X . IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275–306.

36.

36 Dzionek A Sohma Y Nagafune J . BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001; 194: 1823–1834.

37.

37 Blomberg S Eloranta ML Magnusson M Alm GV Ronnblom L . Expression of the markers BDCA-2 and BDCA-4 and producti on of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2524–2532.

38.

38 Dzionek A Inagaki Y Okawa K . Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 2002; 63: 1133–1148.

39.

39 Blanco P Palucka AK Gill M Pascual V Banchereau J . Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540–1543.

40.

40 Migita K Miyashita T Maeda Y . Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol 2005; 142: 84–91.

41.

41 Farkas L Beiske K Lund-Johansen F Brandtzaeg P Jahnsen FL . Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237–243.

42.

42 Banchereau J Pascual V . Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383–392 [Review].

43.

43 Yoshizaki K Kuritani T Kishimoto T . Interleukin-6 in autoimmune disorders. Semin Immunol 1992; 4: 155–166.

44.

44 de Waal Malefyt R Abrams J Bennett B Figdor CG de Vries JE . Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.

45.

45 Rousset F Garcia E Defrance T . Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890–1893.

46.

46 Sotgiu S Pugliatti M Solinas G Castiglia P Sanna A Rosati G . Immunogenetic heterogeneity of multiple sclerosis in Sardinia. Neurol Sci 2001; 22: 167–170.

47.

47 Liu X Steffensen KR Sanna A . Anti-inflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden. Neurobiol Dis 2005; 20: 961–968.